EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The ribosomal S6 kinase 2 (RSK2)–SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling

Jocelyne Lopez, Daniel A Bonsor, Matthew J Sale, Anatoly Urisman, Jennifer L Mehalko, Miranda Cabanski-Dunning, Pau Castel, Dhirendra K Simanshu, Frank McCormick

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.104789 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Jocelyne Lopez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Mitogen-Activated Protein Kinases, Ribosomal Protein S6 Kinases, 90-kDa, Signal Transduction, Repressor Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sprouty-related EVH-1 domain-containing (SPRED) proteins are a family of proteins that negatively regulate the RAS-Mitogen-Activated Protein Kinase (MAPK) pathway, which is involved in the regulation of the mitogenic response and cell proliferation. However, the mechanism by which these proteins affect RAS-MAPK signaling has not been elucidated. Patients with mutations in SPRED give rise to unique disease phenotypes; thus, we hypothesized that distinct interactions across SPRED proteins may account for alternative nodes of regulation. To characterize the SPRED interactome and evaluate how members of the SPRED family function through unique binding partners, we performed affinity purification mass spectrometry. We identified 90-kDa ribosomal S6 kinase 2 (RSK2) as a specific interactor of SPRED2 but not SPRED1 or SPRED3. We identified that the N-terminal kinase domain of RSK2 mediates the interaction between amino acids 123 to 201 of SPRED2. Using X-ray crystallography, we determined the structure of the SPRED2-RSK2 complex and identified the SPRED2 motif, F145A, as critical for interaction. We found that the formation of this interaction is regulated by MAPK signaling events. We also find that this interaction between SPRED2 and RSK2 has functional consequences, whereby the knockdown of SPRED2 resulted in increased phosphorylation of RSK substrates, YB1 and CREB. Furthermore, SPRED2 knockdown hindered phospho-RSK membrane and nuclear subcellular localization. We report that disruption of the SPRED2-RSK complex has effects on RAS-MAPK signaling dynamics. Our analysis reveals that members of the SPRED family have unique protein binding partners and describes the molecular and functional determinants of SPRED2-RSK2 complex dynamics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitogen-Activated Protein KinasesRibosomal Protein S6 Kinases, 90-kDaSignal TransductionRepressor ProteinsPhosphorylationHumansCell LineProtein DomainsGene Knockdown TechniquesProtein TransportProtein BindingProtein Structure, TertiaryModels, MolecularNeurofibromin 1

Stichwörter der Autor:innen

RAS signalingRASopathyRSK2SPRED2kinaseneurofibromin

Substanzen

Mitogen-Activated Protein Kinasesribosomal protein S6 kinase, 90kDa, polypeptide 3Ribosomal Protein S6 Kinases, 90-kDaSPRED2 protein, humanRepressor ProteinsNeurofibromin 1

Autor:innen und Institutionen

  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA.
  • NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Department of Pathology, University of California, San Francisco, San Francisco, California, USA.
  • Protein Expression Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA.
  • Department of Biochemistry and Molecular Pharmacology, New York University, New York, New York, USA.
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA. Electronic address: Frank.mccormick@ucsf.edu.

Förderung

  • NCI NIH HHS
  • NIH HHS
  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • US Office of Congressionally Directed Medical Research Programs
  • University of California, San Francisco
  • Frederick National Laboratory for Cancer Research
  • National Cancer Institute

Zitieren

APA

Lopez, J., Bonsor, D. A., Sale, M. J., Urisman, A., Mehalko, J. L., Cabanski-Dunning, M., Castel, P., Simanshu, D. K., & McCormick, F. (2023). The ribosomal S6 kinase 2 (RSK2)–SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104789

Vancouver

Lopez J, Bonsor DA, Sale MJ, Urisman A, Mehalko JL, Cabanski-Dunning M, et al. The ribosomal S6 kinase 2 (RSK2)–SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104789

BibTeX
@article{Lopez2023,
  author = {Lopez, Jocelyne and Bonsor, Daniel A and Sale, Matthew J and Urisman, Anatoly and Mehalko, Jennifer L and Cabanski-Dunning, Miranda and Castel, Pau and Simanshu, Dhirendra K and McCormick, Frank},
  title = {The ribosomal S6 kinase 2 (RSK2)–SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.104789}
}
Kostenlos starten →